Eurofins Central Laboratory
John Fitzpatrick has a diverse work experience in finance and operations. John is currently serving as the Senior Vice President of Eurofins Central Laboratory since September 2021. Before that, they held positions such as Vice President of Finance and Business Operations and Vice President of Finance at Eurofins Central Laboratory from 2018 to 2021. Prior to joining Eurofins, they worked as the Commercial Director at OpSec Security for a brief period in 2018. From 2014 to 2018, John worked at Eurofins Central Laboratory as the Director of Finance and Operations, Director of Finance, and Senior Business Analyst. John began their career as a Financial Analyst at UGI Energy Services, Inc. from 2011 to 2014 and also worked as a Financial Analyst at Artsana USA, Inc. (Chicco) from 2009 to 2011.
John Fitzpatrick completed their Master of Business Administration (M.B.A.) degree in Business Administration and Management, General from Penn State University between 2010 and 2012. Prior to that, they obtained a Bachelor's degree in Business Administration - Accounting from Millersville University of Pennsylvania. In 2021, John obtained a Certificate in Project Management from Cornell University.
Eurofins Central Laboratory
Eurofins Central Laboratory is a global organization fully focused and dedicated to providing standardized, high quality global central laboratory services to support all phases of clinical trials. Eurofins Central Laboratory supports its customers with 4 wholly-owned and harmonized laboratory facilities located in the US, Europe, Singapore and China. With 25+ years of experience and scientific accomplishment, its laboratory testing portfolio has become one of the widest available in the biopharmaceutical industry and offers the synergy of integrated safety assessment, exploratory biomarkers, end point biomarkers, biomarker development, therapeutic drug monitoring, genomic testing and a full range of services to support vaccine development. Eurofins Central Laboratory provides the highest quality central laboratory services, accurate, timely results capturing the planned completion date, and expert advice from their highly qualified team of experienced scientists.